BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17891697)

  • 1. Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: case report.
    Sökmen M; Demirsoy H; Ersoy O; Gökdemir G; Akbayir N; Karaca C; Ozdil K; Kesici B; Calişkan C; Yilmaz B
    Turk J Gastroenterol; 2007 Sep; 18(3):200-5. PubMed ID: 17891697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda and hematologic malignancy--a report of 4 cases.
    McKenna DB; Browne M; O'Donnell R; Murphy GM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):143-6. PubMed ID: 9453083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda as the most common porphyria.
    Bulat V; Lugović L; Situm M; Buljan M; Bradić L
    Acta Dermatovenerol Croat; 2007; 15(4):254-63. PubMed ID: 18093456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.
    Lederhandler M; Chen L; Meehan SA; Brinster NK; Neimann A
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic porphyria secondary to hepatocellular carcinoma.
    Ochiai T; Morishima T; Kondo M
    Br J Dermatol; 1997 Jan; 136(1):129-31. PubMed ID: 9039312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda and melioidosis.
    Fung WK; Tam SC; Ho KM; Lam P; Lo KK
    Hong Kong Med J; 2001 Jun; 7(2):197-200. PubMed ID: 11514757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Porphyria cutanea tarda and hepatoerythropoietic porphyria].
    Nonaka S; Takamiyagi A
    Nihon Rinsho; 1995 Jun; 53(6):1427-32. PubMed ID: 7616658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
    Felsher BF; Norris ME; Shih JC
    N Engl J Med; 1978 Nov; 299(20):1095-8. PubMed ID: 703786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyria cutanea tarda.
    Bleasel NR; Varigos GA
    Australas J Dermatol; 2000 Nov; 41(4):197-206; quiz 207-8. PubMed ID: 11105361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma presenting with acquired porphyria: a case report and review of the literature.
    Huang WS; Liao LY; Wang CS; Chen PH
    Changgeng Yi Xue Za Zhi; 1999 Mar; 22(1):111-6. PubMed ID: 10418219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda induced by tamoxifen.
    Cruz MJ; Alves S; Baudrier T; Azevedo F
    Dermatol Online J; 2010 Sep; 16(9):2. PubMed ID: 20875323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of porphyria cutanea tarda.
    Sarkany RP
    Clin Exp Dermatol; 2001 May; 26(3):225-32. PubMed ID: 11422163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
    Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
    Quecedo L; Costa J; Enríquez de Salamanca R
    Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.